polyethylene glycol 3350 / potassium chloride / sodium bicarbonate / sodium chloride / sodium sulfate Oral Powder Product
RxNorm concept 1870401, clinical dose form group (scdg).
- RxCUI
- 1870401
- Term type
- Clinical dose form group (SCDG)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1870401 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- potassium chloride (IN, has ingredient)
- sodium chloride (IN, has ingredient)
- sodium bicarbonate (IN, has ingredient)
- sodium sulfate (IN, has ingredient)
- polyethylene glycol 3350 (IN, has ingredient)
- Gavilyte-G Oral Powder Product (SBDG, has tradename)
- Golytely Oral Powder Product (SBDG, has tradename)
- GaviLyte-C Oral Powder Product (SBDG, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1870401 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1870401 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1870401. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.